DK84691D0 - Visse glycolipider og specifikke catchere for disse til anvendelse ved profylaxe eller terapi af diabetes, og/eller dermed forbundne komplikationer samt anvendelse af saadanne glycolipider til detektion af oe-celle-antistoffer (ica) i et individ og anvendelse af saadanne catchere til detektion af langerhans-oe-celler i pancreas-praeparater - Google Patents
Visse glycolipider og specifikke catchere for disse til anvendelse ved profylaxe eller terapi af diabetes, og/eller dermed forbundne komplikationer samt anvendelse af saadanne glycolipider til detektion af oe-celle-antistoffer (ica) i et individ og anvendelse af saadanne catchere til detektion af langerhans-oe-celler i pancreas-praeparaterInfo
- Publication number
- DK84691D0 DK84691D0 DK91846A DK84691A DK84691D0 DK 84691 D0 DK84691 D0 DK 84691D0 DK 91846 A DK91846 A DK 91846A DK 84691 A DK84691 A DK 84691A DK 84691 D0 DK84691 D0 DK 84691D0
- Authority
- DK
- Denmark
- Prior art keywords
- therapy
- cells
- methods
- cellipols
- glycolipides
- Prior art date
Links
- 238000002560 therapeutic procedure Methods 0.000 title 2
- 241001465754 Metazoa Species 0.000 title 1
- 210000000496 pancreas Anatomy 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
- 238000000034 method Methods 0.000 abstract 5
- 206010018429 Glucose tolerance impaired Diseases 0.000 abstract 3
- 208000001280 Prediabetic State Diseases 0.000 abstract 3
- 206010012601 diabetes mellitus Diseases 0.000 abstract 3
- 210000004153 islets of langerhan Anatomy 0.000 abstract 3
- 201000009104 prediabetes syndrome Diseases 0.000 abstract 3
- HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 abstract 2
- 229930186217 Glycolipid Natural products 0.000 abstract 2
- 239000013543 active substance Substances 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 238000012544 monitoring process Methods 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
- C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Priority Applications (10)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK91846A DK84691D0 (da) | 1991-05-07 | 1991-05-07 | Visse glycolipider og specifikke catchere for disse til anvendelse ved profylaxe eller terapi af diabetes, og/eller dermed forbundne komplikationer samt anvendelse af saadanne glycolipider til detektion af oe-celle-antistoffer (ica) i et individ og anvendelse af saadanne catchere til detektion af langerhans-oe-celler i pancreas-praeparater |
| AT92910435T ATE175203T1 (de) | 1991-05-07 | 1992-05-07 | Sulfatierte glykolipide, die eine galaktose-3-0- sulfate-gruppierung enthalten, und spezifische fänger für diese für die verwendung in der prophylaxe oder therapie der prädiabetis, diabetis und/oder damit zusammenhängender komplikationen in einem individuum |
| DE69228061T DE69228061T2 (de) | 1991-05-07 | 1992-05-07 | Sulfatierte glykolipide, die eine galaktose-3-0-sulfate-gruppierung enthalten, und spezifische fänger für diese für die verwendung in der prophylaxe oder therapie der prädiabetis, diabetis und/oder damit zusammenhängender komplikationen in einem individuum |
| AU17888/92A AU1788892A (en) | 1991-05-07 | 1992-05-07 | Sulfated glycolipids, containing a galactose-3-0-sulfate moiety, and specific catchers therefor for use in the prophylaxis or therapy of prediabetes, diabetes and/or associated complications in an individual |
| PCT/DK1992/000146 WO1992019633A1 (en) | 1991-05-07 | 1992-05-07 | Sulfated glycolipids, containing a galactose-3-0-sulfate moiety, and specific catchers therefor for use in the prophylaxis or therapy of prediabetes, diabetes and/or associated complications in an individual |
| EP92910435A EP0584175B1 (en) | 1991-05-07 | 1992-05-07 | Sulfated glycolipids, containing a galactose-3-0-sulfate moiety, and specific catchers therefor for use in the prophylaxis or therapy of prediabetes, diabetes and/or associated complications in an individual |
| ES92910435T ES2125898T3 (es) | 1991-05-07 | 1992-05-07 | Glicolipidos sulfatados que contienen un resto de galactosa-3-0-sulfato, y captadores especificos para los mismos, para uso en profilaxis o terapia de prediabetes, diabetes y/o complicaciones asociadas en un individuo. |
| DK92910435T DK0584175T3 (da) | 1991-05-07 | 1992-05-07 | Sulfaterede glycolipider, der indeholder en galactose-3-0-sulfatdel, og specifikke fangere dertil til anvendelse i profylak |
| JP51038492A JP3222465B2 (ja) | 1991-05-07 | 1992-05-07 | 個体の糖尿病前症、糖尿病および／または関連合併症の予防または治療に用いる、ガラクトース−３−０−サルフェート部分を含有する硫酸化糖脂質類およびその特異的キャッチャー |
| US08/396,802 US5827828A (en) | 1991-05-07 | 1995-02-28 | Sulfated glycolipids and antibodies thereto for prophylaxis or therapy of diabetes |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK91846A DK84691D0 (da) | 1991-05-07 | 1991-05-07 | Visse glycolipider og specifikke catchere for disse til anvendelse ved profylaxe eller terapi af diabetes, og/eller dermed forbundne komplikationer samt anvendelse af saadanne glycolipider til detektion af oe-celle-antistoffer (ica) i et individ og anvendelse af saadanne catchere til detektion af langerhans-oe-celler i pancreas-praeparater |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK84691D0 true DK84691D0 (da) | 1991-05-07 |
Family
ID=8098211
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK91846A DK84691D0 (da) | 1991-05-07 | 1991-05-07 | Visse glycolipider og specifikke catchere for disse til anvendelse ved profylaxe eller terapi af diabetes, og/eller dermed forbundne komplikationer samt anvendelse af saadanne glycolipider til detektion af oe-celle-antistoffer (ica) i et individ og anvendelse af saadanne catchere til detektion af langerhans-oe-celler i pancreas-praeparater |
| DK92910435T DK0584175T3 (da) | 1991-05-07 | 1992-05-07 | Sulfaterede glycolipider, der indeholder en galactose-3-0-sulfatdel, og specifikke fangere dertil til anvendelse i profylak |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK92910435T DK0584175T3 (da) | 1991-05-07 | 1992-05-07 | Sulfaterede glycolipider, der indeholder en galactose-3-0-sulfatdel, og specifikke fangere dertil til anvendelse i profylak |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US5827828A (da) |
| EP (1) | EP0584175B1 (da) |
| JP (1) | JP3222465B2 (da) |
| AT (1) | ATE175203T1 (da) |
| AU (1) | AU1788892A (da) |
| DE (1) | DE69228061T2 (da) |
| DK (2) | DK84691D0 (da) |
| ES (1) | ES2125898T3 (da) |
| WO (1) | WO1992019633A1 (da) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5580858A (en) * | 1991-06-10 | 1996-12-03 | Alberta Research Council | Immunosuppressive and tolerogenic modified Lewisx compounds |
| US5663151A (en) * | 1994-03-04 | 1997-09-02 | Bristol-Myers Squibb Company | Sulfated α-glycolipid derivatives as cell adhesion inhibitors |
| CA2142153A1 (en) * | 1994-03-04 | 1995-09-05 | Jacques Banville | Sulfated .beta.-glycolipid derivatives as cell adhesion inhibitors |
| US5686426A (en) | 1994-11-17 | 1997-11-11 | Bristol-Myers Squibb Company | Dicarboxymethylated glycolipid derivatives as cell adhesion inhibitors |
| SE9601817D0 (sv) | 1996-05-13 | 1996-05-13 | Karsten Buschard | Novel glycolipid complexex and their uses |
| CN1768759A (zh) * | 1997-04-10 | 2006-05-10 | 麒麟麦酒株式会社 | 神经酰胺化合物在制备细胞活化剂中的应用 |
| WO1999033475A1 (en) * | 1997-12-30 | 1999-07-08 | A+ Science Invest Ab | Galactosylceramide, glucosylceramide, lactosylceramide, and specific catchers therefor for use in the prophylaxis or therapy of prediabetes, diabetes and/or associated complications |
| SE0000258D0 (sv) * | 2000-01-27 | 2000-01-27 | A & Science Invest Ab | Pharmaceutical preparation and method for treatment of diabetes |
| JP4064346B2 (ja) | 2001-08-16 | 2008-03-19 | アスビオファーマ株式会社 | 新規な糖脂質及びこれを有効成分とする自己免疫疾患治療薬 |
| JP5564672B2 (ja) | 2006-06-30 | 2014-07-30 | ザ スクリプス リサーチ インスティテュート | アジュバント及びその使用方法 |
| FR2926972B1 (fr) * | 2008-02-05 | 2011-03-11 | Technologia | Appareil de diagnostic precoce du syndrome du canal carpien et procede et dispositif d'acquisition de l'information relative a la sensibilite cutanee du doigt du patient |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5288706A (en) * | 1987-12-25 | 1994-02-22 | Mitsui Toatsu Chemicals, Incorporated | Medicament for prevention and remedy of diseases of the pancreas and others |
-
1991
- 1991-05-07 DK DK91846A patent/DK84691D0/da not_active Application Discontinuation
-
1992
- 1992-05-07 JP JP51038492A patent/JP3222465B2/ja not_active Expired - Fee Related
- 1992-05-07 ES ES92910435T patent/ES2125898T3/es not_active Expired - Lifetime
- 1992-05-07 WO PCT/DK1992/000146 patent/WO1992019633A1/en active IP Right Grant
- 1992-05-07 DK DK92910435T patent/DK0584175T3/da active
- 1992-05-07 EP EP92910435A patent/EP0584175B1/en not_active Expired - Lifetime
- 1992-05-07 AU AU17888/92A patent/AU1788892A/en not_active Abandoned
- 1992-05-07 DE DE69228061T patent/DE69228061T2/de not_active Expired - Fee Related
- 1992-05-07 AT AT92910435T patent/ATE175203T1/de not_active IP Right Cessation
-
1995
- 1995-02-28 US US08/396,802 patent/US5827828A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP0584175B1 (en) | 1998-12-30 |
| JPH06506943A (ja) | 1994-08-04 |
| ATE175203T1 (de) | 1999-01-15 |
| DE69228061D1 (de) | 1999-02-11 |
| JP3222465B2 (ja) | 2001-10-29 |
| DE69228061T2 (de) | 1999-05-27 |
| WO1992019633A1 (en) | 1992-11-12 |
| DK0584175T3 (da) | 1999-08-30 |
| US5827828A (en) | 1998-10-27 |
| AU1788892A (en) | 1992-12-21 |
| EP0584175A1 (en) | 1994-03-02 |
| ES2125898T3 (es) | 1999-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK84691D0 (da) | Visse glycolipider og specifikke catchere for disse til anvendelse ved profylaxe eller terapi af diabetes, og/eller dermed forbundne komplikationer samt anvendelse af saadanne glycolipider til detektion af oe-celle-antistoffer (ica) i et individ og anvendelse af saadanne catchere til detektion af langerhans-oe-celler i pancreas-praeparater | |
| DK120184D0 (da) | Materiale og middel til detektering af naervaerelsen af et peroxidativt aktivt stof i en testproeve,samt fremstilling og anvendelse deraf | |
| EP0370274A3 (en) | Personal computer/host emulation system for handling host data with personal computer application programs at personal computers | |
| GB1284476A (en) | Potassium ion sensitive electrode | |
| Hiromatsu et al. | Inhibitory effects of nicotinamide on recombinant human interferon-gamma-induced intercellular adhesion molecule-1 (ICAM-1) and HLA-DR antigen expression on cultured human endothelial cells | |
| Sargent et al. | Characterization and biosynthesis of cytochrome b 5 in rat liver microsomes | |
| NO973026L (no) | Nye monoklonale antistoffer med virksom inhibitorisk aktivitet mot type II-fosfolipase A2 og proteiner omfattende en del derav | |
| Aizawa et al. | Cell surface changes accompanying aging in human diploid fibroblasts: V. Role of large major cell surface protein and surface negative charge in aging-and transformation-associated changes in concanavalin A-mediated red blood cell adsorption | |
| JPS52126136A (en) | Disfigurement detecting system using figure outline information | |
| NO920624L (no) | Reagens for paavisning av fibrinolytisk aktivitet | |
| Venkatakrishnan et al. | Arginase activity in mitochondria–An interfering factor in nitric oxide synthase activity assays | |
| De Vries et al. | Biliary excretion of phenprocoumon and metabolites. | |
| Nelson et al. | Theophylline concentrations may be falsely high in serum of uremic patients. | |
| Chang et al. | Reaction of concanavalin A with alkaline phosphatases extracted from various human tissue sources | |
| Self et al. | A new sensitive and fast peptide immunoassay based on enzyme amplification used in the determination of CGRP and the demonstration of its presence in the thyroid | |
| DK70488D0 (da) | Fremgangsmaade til paavisning af antistoffer i blod, samt membran og test-saet til anvendelse ved udoevelse af fremgangsmaaden | |
| DK116487D0 (da) | Fremgangsmaade til eksponering af en epitop i et protein med bestemt polypeptidstruktur, samt vektorer til brug ved fremgangsmaaden, hybridproteiner omfattende epitopen, og anvendelse af hybridproteinet ved diagnoser. | |
| Habior | Effect of captopril on glutathione level in the liver and paracetamol-induced liver damage in rats | |
| Myers et al. | Hemoglobin adducts of benzo [a] pyrene in tobacco smokers: characterization of benzo [a] pyrene adducts in maternal and fetal blood samples | |
| SE7705987L (sv) | Referensmaterial for att uppretthalla anjonkoncentrationer vid analytiska kemiska tester, samt framstellning och anvendning derav | |
| Brown | Surface analysis of materials by static SIMS and FABMS. | |
| Bakay et al. | Effects of thalidomide and chlorcyclizine on the biosynthesis of nucleic acids and proteins in fetal and maternal tissues of the rat | |
| LIEBOWITZ | Fracture mechanics of aircraft structures(proceedings of conference on structural characteristics of aircraft components) | |
| Goodman et al. | Specificity of the action of parathyroid hormone upon mitochondrial metabolism: Cyanogen bromide-derived parathyroid-hormone peptides | |
| Joiner et al. | Multiple animal studies for medical chemical defense program in soldier/patient decontamination and drug development on task 88-36: Development of in vitro screening assays for candidate pretreatment and treatment compounds. Final report, 1 July 1988-1 July 1989 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AHS | Application shelved for other reasons than non-payment |